Literature DB >> 31579653

Gaps in tuberculosis care in West Sepik Province of Papua New Guinea.

T Kelebi1, K C Takarinda2,3, R Commons4,5, B Sissai1, J Yowei1, M Gale4.   

Abstract

SETTING: Papua New Guinea (PNG), a low-resource country with a high tuberculosis (TB) burden.
OBJECTIVE: To describe the characteristics, treatment outcomes and risk factors for unfavourable outcomes among patients registered for first-line tuberculosis (TB) treatment between 1 January 2014 and 31 December 2016 in West Sepik Province.
DESIGN: This was a retrospective cohort study of routinely collected programme data.
RESULTS: Of 1058 cases, 50.7% were male and 38.8% were aged <15 years; 43.1% were extrapulmonary TB cases and 280 (26.5%) were bacteriologically confirmed. No human immunodeficiency virus (HIV) status was recorded for 74.7% of cases. Of 1019 (96.3%) patients with a recorded outcome, 779 (76.4%) were favourable and 240 (23.6%) were unfavourable. On multivariable logistic regression, increasing age was associated with an increased odds of an unfavourable outcome (adjusted OR [aOR] 1.06 per every 5-year increase, 95%CI 1.02-1.11; P = 0.006) and being a retreatment case was associated with a reduced odds of an unfavourable outcome compared to new cases (aOR 0.54, 95%CI 0.31-0.93; P = 0.027).
CONCLUSION: This study identified substantial gaps in TB care, including low rates of bacteriological diagnosis and HIV testing, and high rates of loss to follow-up, highlighting the need to strengthen TB control efforts, including support for new cases.
© 2019 The Union.

Entities:  

Keywords:  HIV; loss to follow-up; rural health

Year:  2019        PMID: 31579653      PMCID: PMC6735461          DOI: 10.5588/pha.18.0057

Source DB:  PubMed          Journal:  Public Health Action        ISSN: 2220-8372


  7 in total

1.  Trends in tuberculosis incidence and their determinants in 134 countries.

Authors:  C Dye; K Lönnroth; E Jaramillo; B G Williams; M Raviglione
Journal:  Bull World Health Organ       Date:  2009-09       Impact factor: 9.408

Review 2.  Patient adherence to tuberculosis treatment: a systematic review of qualitative research.

Authors:  Salla A Munro; Simon A Lewin; Helen J Smith; Mark E Engel; Atle Fretheim; Jimmy Volmink
Journal:  PLoS Med       Date:  2007-07-24       Impact factor: 11.069

Review 3.  Tuberculosis Treatment Non-Adherence and Lost to Follow Up among TB Patients with or without HIV in Developing Countries: A Systematic Review.

Authors:  Habteyes Hailu Tola; Azar Tol; Davoud Shojaeizadeh; Gholamreza Garmaroudi
Journal:  Iran J Public Health       Date:  2015-01       Impact factor: 1.429

4.  The social determinants of tuberculosis treatment adherence in a remote region of Papua New Guinea.

Authors:  Tanya Diefenbach-Elstob; David Plummer; Robert Dowi; Sinba Wamagi; Bisato Gula; Keyanato Siwaeya; Daniel Pelowa; Peter Siba; Jeffrey Warner
Journal:  BMC Public Health       Date:  2017-01-13       Impact factor: 3.295

5.  Tuberculosis treatment outcomes among disadvantaged patients in India.

Authors:  C Jackson; H R Stagg; A Doshi; D Pan; A Sinha; R Batra; S Batra; I Abubakar; M Lipman
Journal:  Public Health Action       Date:  2017-06-21

6.  Treatment outcomes of tuberculosis patients in nigist Eleni Mohammed general hospital, hosanna, southern nations, nationalities and peoples region, Ethiopia: a five year (June 2009 to August 2014) retrospective study.

Authors:  Tigist Mohammed; Kidist Daniel; Degefa Helamo; Taye Leta
Journal:  Arch Public Health       Date:  2017-04-03

Review 7.  Epidemiology of tuberculosis in Papua New Guinea: analysis of case notification and treatment-outcome data, 2008-2016.

Authors:  Paul Aia; Lungten Wangchuk; Fukushi Morishita; Jacob Kisomb; Robin Yasi; Margaret Kal; Tauhid Islam
Journal:  Western Pac Surveill Response J       Date:  2018-06-15
  7 in total
  1 in total

1.  Factors associated with loss to follow-up among TB patients in rural Papua New Guinea.

Authors:  I Umo; M Kulai; R J Commons
Journal:  Public Health Action       Date:  2021-12-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.